Literature DB >> 11788886

Characteristics of mitotic cell death induced by enediyne antibiotic lidamycin in human epithelial tumor cells.

Qi Yang He1, Yun Yan Liang, Dai Shu Wang, Dian Dong Li.   

Abstract

Mitotic cell death, a different cell death mode from apoptosis, has been focused on in tumor therapy. It may involve the mechanism of highly potent cytotoxicities of enediyne antibiotics toward tumor cells. We describe the characteristics of mitotic cell death induced by enediyne antibiotic lidamycin at low concentrations (0.01-1 nM), in the human hepatoma BEL-7402 cells and human breast carcinoma MCF-7 cells. The cells exerting mitotic cell death showed retardation at G2+M phase, enlargement of cell volume and multinucleation, some of which were positive in senescence-associate beta-galactosidase staining. The multinucleated living cells did not show apoptotic features by co-staining with mitochondria-specific dye Mitosensor and DNA-specific dye Hoechst 33342. The DNA polyploidy rather than <apoptotic sub-G1 peak> increased with incubation time for the lidamycin-treated BEL-7402 cells. The proliferation status of BEL-7402 cells was shown by flow cytometry after the cells were labeled with PKH-67, a fluorescent dye for labeling living cells, but the fluorescent intensity of the lidamycin-treated cells was little changed. The smear DNA pattern was detected in the multinucleated cells by agarose gel electrophoresis. The results provide the first evidence for elucidating the potent cytotoxicities of lidamycin toward tumor cells and further describing characteristics of mitotic cell death.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788886

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  9 in total

1.  Mitotic cell death in BEL-7402 cells induced by enediyne antibiotic lidamycin is associated with centrosome overduplication.

Authors:  Yue-Xin Liang; Wei Zhang; Dian-Dong Li; Hui-Tu Liu; Ping Gao; Yi-Na Sun; Rong-Guang Shao
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

2.  Inhibition of mouse embryonic carcinoma cell growth by lidamycin through down-regulation of embryonic stem cell-like genes Oct4, Sox2 and Myc.

Authors:  Hong-Ying Zhen; Qi-Hua He; Yong-Zhan Zhen; Shu-Ling Wang; Yi-Nan Liu; Wei-Hua Wu; Xiao-Yan Zhang; Ai-Li Lu; Li Shen
Journal:  Invest New Drugs       Date:  2010-07-02       Impact factor: 3.850

3.  Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule.

Authors:  Yun-Hong Huang; Bo-Yang Shang; Yong-Su Zhen
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

4.  Pharmacokinetics of C-1027 in mice as determined by TCA-RA method.

Authors:  You-Ping Liu; Quan-Sheng Li; Yu-Rong Huang; Mao-Jin Zhou; Chang-Xiao Liu
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

5.  Antitumor activity of anti-type IV collagenase monoclonal antibody and its lidamycin conjugate against colon carcinoma.

Authors:  Liang Li; Yun-Hong Huang; Yi Li; Feng-Qiang Wang; Bo-Yang Shang; Yong-Su Zhen
Journal:  World J Gastroenterol       Date:  2005-08-07       Impact factor: 5.742

6.  Lidamycin shows highly potent cytotoxic to myeloma cells and inhibits tumor growth in mice.

Authors:  Yong-Zhan Zhen; Ya-Jun Lin; Yi Li; Yong-Su Zhen
Journal:  Acta Pharmacol Sin       Date:  2009-07       Impact factor: 6.150

7.  PLSCR1/IP3R1/Ca2+ axis contributes to differentiation of primary AML cells induced by wogonoside.

Authors:  Hui Li; Jingyan Xu; Yuxin Zhou; Xiao Liu; L E Shen; Y U Zhu; Zhiyu Li; Xiaotang Wang; Qinglong Guo; Hui Hui
Journal:  Cell Death Dis       Date:  2017-05-11       Impact factor: 8.469

Review 8.  Podocyte mitosis - a catastrophe.

Authors:  L Lasagni; E Lazzeri; S J Shankland; H-J Anders; P Romagnani
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

9.  Tissue factor-targeted lidamycin inhibits growth and metastasis of colon carcinoma.

Authors:  Qing Zhang; Xiujun Liu; Caihong Li; Dongsheng Liao; Zhigang Ouyang; Junnian Zheng; Xu Song
Journal:  Oncol Lett       Date:  2013-07-03       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.